Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H13N3O2 |
| Molecular Weight | 291.304 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)N2N=C3C(=CNC4=C3C=CC=C4)C2=O
InChI
InChIKey=KSKRJZMRHSNRBX-UHFFFAOYSA-N
InChI=1S/C17H13N3O2/c1-22-12-8-6-11(7-9-12)20-17(21)14-10-18-15-5-3-2-4-13(15)16(14)19-20/h2-10,18H,1H3
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/2442653Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/27319298 | https://www.ncbi.nlm.nih.gov/pubmed/8388472 | https://google.com/patents/EP0022078B1 | https://www.ncbi.nlm.nih.gov/pubmed/3001268
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2442653
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/27319298 | https://www.ncbi.nlm.nih.gov/pubmed/8388472 | https://google.com/patents/EP0022078B1 | https://www.ncbi.nlm.nih.gov/pubmed/3001268
CGS-9895 is nanomolar null modulator (antagonist) at the benzodiazepine binding site and at micromolar concentrations also modulate the receptors via the α+β- interface. The modulatory action of CGS 9895 is sensitive to the types of a and b subunit isoforms present in the receptor.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL1907607 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6121916 |
0.1 nM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6090169
Male CD1 mice were deprived of food for at least 2 h before oral administration of CGS-9895 (0.1, 0.3, 1, 3, 10, 30, 100 mg/kg). 1 h after drug treatment, mice were challenged with 60 mg/kg i.v. pentylenetetrazole. No antipentylenetetrazole activity of CGS 9895 could be detected at doses from 1-100 mg/kg.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2442653
The membranes from rat forebrains were prepared and washed. [35S]TBPS binding responses to varying concentrations of diazepam were measured in the presence or absence of 800 nM diazepam. Varying concentrations of CGS 9895 were coincubated with either the solvent or 800 nM diazepam. CGS 9895 increased [35S]TBPS binding in a concentration-dependent manner
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID80998971
Created by
admin on Mon Mar 31 18:57:23 GMT 2025 , Edited by admin on Mon Mar 31 18:57:23 GMT 2025
|
PRIMARY | |||
|
VEN7HT4FPL
Created by
admin on Mon Mar 31 18:57:23 GMT 2025 , Edited by admin on Mon Mar 31 18:57:23 GMT 2025
|
PRIMARY | |||
|
373970
Created by
admin on Mon Mar 31 18:57:23 GMT 2025 , Edited by admin on Mon Mar 31 18:57:23 GMT 2025
|
PRIMARY | |||
|
77779-50-1
Created by
admin on Mon Mar 31 18:57:23 GMT 2025 , Edited by admin on Mon Mar 31 18:57:23 GMT 2025
|
PRIMARY | |||
|
100812
Created by
admin on Mon Mar 31 18:57:23 GMT 2025 , Edited by admin on Mon Mar 31 18:57:23 GMT 2025
|
PRIMARY | |||
|
2650307-15-4
Created by
admin on Mon Mar 31 18:57:23 GMT 2025 , Edited by admin on Mon Mar 31 18:57:23 GMT 2025
|
ALTERNATIVE |
SUBSTANCE RECORD